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Regarding the outdoor behavior of the Caucasian
population, modern sunscreens should provide high
and broad-spectrum ultraviolet protection in the
ultraviolet B as well as in the ultraviolet A range and
should be photochemically stable for ultraviolet
doses, which can be expected in solar radiation. At
present an assessment of the photostability of suncare
products is not a general requirement before market-
ing. In order to evaluate the photostability of suncare
products we conducted an in vitro test and measured
the spectral absorbance of 16 sunscreens before, and
after exposure to increasing biologically weighted
standard erythema doses (5, 12.5, 25, 50) of solar-
simulated radiation. Seven of 16 suncare products
showed a signi®cant dose- and wavelength-depend-
ent decrease of the ultraviolet A protective capacity,
whereas the ability to absorb ultraviolet B was not
affected. In the ultraviolet A range, the decrease of
absorbance (photoinactivation), respectively, the
increase of transmission was 12±48% for an ultravio-
let exposure of 25 standard erythema dose.
Photoinactivation started in the wavelength range
between 320 and 335 nm with a maximum above
350 nm. Furthermore, our analysis showed that the
behavior of suncare products was not predictable
from its individual ingredients. Neither complex
combinations of organic ®lters nor addition of inor-
ganic ®lters could absolutely prevent photoinactiva-
tion. The inclusion of a single photounstable ®lter
did not mean photoinstability of the complete sun-
care product. Photoinactivation of sunscreens
appears to be an underestimated hazard to the skin,
®rst, by formation of free radicals, second, by
increased ultraviolet A transmission. Key words: photo-
instability/standard erythema dose/ultraviolet exposure/
photodamage/solar radiation. J Invest Dermatol 117:256±
262, 2001
R
ecent studies show that regular use of sunscreens
reduces the carcinogenic risk (Thompson et al,
1993; Fourtanier, 1996), provides protection against
immune suppression (Wolf et al, 1993; Krien and
Moyal, 1994; Damian et al, 1997; Serre et al, 1997)
and prevents photoaging (Harrison et al, 1991; Bernstein et al,
1997). It has been pointed out repeatedly that ultraviolet (UV) A
radiation (320±380 nm) contributes to skin photodamage (Parrish
et al, 1978). Photodamage is predicted to become a major threat to
public health in the coming decades (Kaminer, 1995); therefore, in
addition to a high protection in the UVB range (280±320 nm) also
protection against UVA radiation appears to be mandatory (Young
and Walker, 1999). A new generation of broad-spectrum
sunscreens provides high protective capacity in both, the UVA
and UVB range. The major advantage of these suncare products
should be a more effective protection of acute and chronic adverse
effects of solar UV radiation to skin areas usually exposed to
sunlight (face, hands, lower legs) and areas exposed under special
conditions (outdoor work, outdoor sport). The misleading
advertising of a ``safe tan'' by sunscreen producers, however,
encourages people to (mis)use modern sunscreens in order to stay
much longer in the sun (Boldeman et al, 1996; Autier et al, 1998).
Prolonged exposure time together with a wrong self-assessment of
the personal burning capacity (Stender et al, 1996) and incorrect
mode of application (Azurdia et al, 1999; Pruim et al, 1999) reduces
the bene®ts of high protective factors and broad-spectrum
protection. At present, it appears that in public opinion sunscreens
are regarded as ®rst-line photoprotective modality. This is the
reason why an International Working Group of experts convened
by the International Agency for Research on Cancer (IARC) of the
World Health Organization (WHO) concluded that sunscreens
should be only one part of a comprehensive sun avoidance strategy
(IARC, 2000a). The most important recommendations on sun
behavior forwarded by the IARC are, moving into the shade,
wearing UV protective clothing (IARC, 2000b) and that
advertising should avoid promoting sunscreens for intentional sun
exposure (IARC, 2000b). Furthermore, evidence is increasing that
sunscreens may not be as harmless as they have been supposed to be
(Knowland et al, 1997). Suncare products are a mixture of many
different ingredients, all of them should resist UV doses relevant for
a sunny day. It was shown, however, that certain organic UV ®lters
are inactivated by UV radiation (Chignell et al, 1980; Gasparro,
1985; Knowland et al, 1993; Schwack and Rudolph, 1995; Allen
et al, 1996; Berset et al, 1996; Schallreuter et al, 1996; Tarras-
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Wahlberg et al, 1999; Vanquerp et al, 1999), lose their UV
protective capacity (Diffey et al, 1997) and may behave as photo-
oxidants (Allen et al, 1996; Schallreuter et al, 1996; McHugh and
Knowland, 1997). This is of utmost signi®cance because ®lter
molecules penetrate through the epidermis (Kenney et al, 1995;
Hayden et al, 1997; Jiang et al, 1999) and highly reactive
intermediates of photounstable ®lter substances get in direct contact
with epidermal and dermal structures (Schallreuter et al, 1996;
Gulston and Knowland, 1999). Furthermore, Hayden et al (1997)
recovered oxybenzone as unchanged oxybenzone and metabolites
in the urine after topical application. From this point of view it is
surprising that at present standardized photostability tests of ®nished
suncare products are not required before marketing, although this
has been recommended repeatedly (Berset et al, 1996; Vanquerp
et al, 1998; Sayre and Dowdy, 1999; IARC, 2000b).
MATERIALS AND METHODS
Measurements We purchased 16 commercially available sunscreens
(products A±Q) with declared UVA and UVB protection (Table I).
Nine creams/lotions (products H±Q) were recommended by the
producer for use in infancy and childhood. The samples were stored at
room temperature and in the dark and opened immediately before our
test procedure. By circular movements of a gloved ®nger quartz glass
slides were covered with a layer of 1.5 6 0.15 mg per cm2 for the
standard products (A±G)1 according to the guidelines for the evaluation
of sunscreen products DIN 67501 (Deutsches Institut fuÈr Normung) and
2.0 6 0.2 mg per cm2 for child products (H±Q) according to the
COLIPA (European Cosmetic, Toiletry and Perfumery Association)
guidelines to measure the sun protection factor (SPF) of sunscreens. The
correct quantity was checked immediately after application by a
laboratory balance. The samples were dried for 30 min at constant
temperature (26°C) and constant relative humidity (50%). Thereafter, the
slides were irradiated with a solar simulator (COLIPA Dermasun Dr
HoÈnle 400F/5, Planegg, Germany) at a radiometrically (Solar Light SL
5D, Solar Light, Philadelphia, PA) de®ned, homogeneous ®eld of
irradiance. By using the standard erythema dose (SED) (CIE, 1998), the
mean biologically effective irradiance was 12.75 SED per h,
corresponding to solar radiation at midsummer noon and cloudless sky in
central Europe. The variability of the radiation ®eld was 5.3%, which is
signi®cantly below the limit of the COLIPA guidelines. During the
entire irradiation time the temperature and humidity were kept constant
at 26°C and 50%, respectively. The spectral irradiance of the solar
simulator was measured by using a spectroradiometer with a double
monochromator (Bentham, DTM 300, Bentham, Reading, U.K.) and a
photomultiplier (Bentham, DH-1 (Bi), Bentham, Reading, UK) ful®lling
Table I. Sunscreen active ingredients and declaration of photobiologically relevant data on package
Filter substances (chemical
®lters according to
CTFAa/INCIb)
Sunscreen producth
A B C D E F G H I K L M N O P Q
Zinc oxide x
Titanium dioxide x x x x x x x x x x x x x
Octocrylene x x x x
Benzophenone-3 x
Phenyldibenzimidazole
sulfonic acid
x x
Terephthalylidene
dicamphor sulfonic acid
x x x
Butyl
methoxydibenzoylmethane
x x x x x x x x x x x x x x
Mexoryl SX x
Isoamyl p-
methoxycinnamate
x x x
Octyl methoxycinnamate x x x x x x x x x x x
Methylbenzylidene
camphor
x x x x x x x x x x x x
Octyl triazone x x x x x
Broad spectrum
protection made
evident
x x x x x x x x x x x x x x x x
SPFc 20 18 20 20 20 16 18 20 24 18 25 26g 25 25 18 18
UVA protection
factor/method of
assessment
AUSd 7PPDe
18 IPDf
AUS AUS AUS AUS 10 PPD AUS AUS
Photostability made
evident
x x
aCosmetic Toiletry and Fragrance Association.
bInternational Nomenclature Cosmetic Ingredient.
cSun Protection Factor.
dAustralian Standard.
ePermanent Pigment Darkening.
fImmediate Pigment Darkening.
gIn all other European countries only available with SPF = 25.
hSunscreen producers: A Ambre Solaire Intensivschutz Sonnenmilch (Laboratoires Garnier, Paris, France); B AS SUN Sonnenmilch (E. Kiessling & Cie GmbH & Co.,
GeorgensgmuÈnd, Germany); C delial Sensitive Sonnen Balm (Bayer AG, Leverkusen, Germany); D Anthelios Sonnenmilch (La Roche-Posay Laboratoire Pharmaceutique,
La Roche ± Posay, France); E Nivea Sun Sonnenmilch (Beiersdorf AG, Hamburg, Germany); F Nivea Sun Sonnen Balsam (Beiersdorf AG, Hamburg, Germany); G
Tiroler NussoÈ l Sensitiv Sonnen Milch (Tiroler NussoÈl Sonnenkosmetik, MuÈnchen, Germany); H AS Sonnenmilch fuÈr Kinder (E. Kiessling & Cie GmbH. & Co
GeorgensgmuÈnd, Germany); I Ellen Betrix Sun Care Sonnenmilch fuÈr Kinder (P & G, Weybridge, UK); K Nivea Sun Sonnenmilch fuÈr Kinder (Beiersdorf AG, Hamburg,
Germany; L Ambre Solaire Kinder Intensivschutz Sonnenmilch (Laboratoires Garnier, Paris, France); M Delial Sonnenmilch fuÈr Kinder (Sara Lee, DuÈsseldorf, Germany); N
Vichy Capital Soleil Sunblocker-Milch speziell fuÈr Kinderhaut (Vichy Laboratoires, Vichy, France); O pH5-Eucerin Sun Sensitive Kinder Lotio (Beiersdorf AG, Hamburg,
Germany); P BuÈbchen Sonnen Milk (BuÈbchen Werk Ewald Hermes Pharmazeutische Fabrik GmbH, Soest, Germany); Q Penaten Baby Sonnenmilch (Johnson & Johnson
GmbH, DuÈsseldorf, Germany).
1Maier H, Brunnhofer K, Schauberger G, HoÈnigsmann H:
Photoinactivation of sun protection products. Arch Dermatol Res 290:34,
1998 (abstr.)
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the requirements of the COLIPA guidelines (Fig 1). The ®rst series of
suncare products (A±G) was exposed up to 50 SED, the second series
recommended for children (H±Q) was exposed up to 25 SED.
We measured the spectral absorbance (ratio of the absorbed radiant
¯ux to the incident ¯ux according to the CIE International Lighting
Vocabulary; CIE, 1987) (in percentage) for the 16 sunscreens in both,
the UVA (320±380 nm) and UVB (280±320 nm) range before, after
5 SED (products A, C, E, H±Q), 12.5 and 25 SED (all products), and
50 SED (products A±G) of solar-simulated UV radiation with a reso-
lution of 1 nm by a spectrophotometer (Varian Cary 3E, Varian Australia
PTY Ltd, Mulgrave, Victoria, Australia) connected with a sphere
(Labsphere DRA-CA-30, Labsphere, North Sutton, NH) (Marginean
et al, 1995). This instrument is a double-beam, ratio-recording spectro-
photometer that automatically performs a baseline correction. To cut off
¯uorescent effects the sphere was armed with a Schott UG 11 ®lter
(Schott, Mainz, Germany) according to the Australian/New Zealand
Standard AS/NZS 4399 (1996). In order to keep the samples in an
identical position during consecutive measurements we added a steel
frame (inner measurements 25 3 80 mm) to the provided transmittance
sample holder. The quartz glass slides were put into the tight ®tting
frame and ®xed by a shutter. An aperture faded out the lateral portions
of the sample and allowed transmission only in a central ®eld of
approximately 6 cm2. The sample holder was screwed up in the
transmittance sample port. Two samples of each suncare product of the
same lot are stored under standardized conditions.
Data analyses In order to describe the effect of photoinstability we
used the spectral photoinactivation, DAeÈ, due to the UV exposure,
calculated by the difference between the spectral absorbance, AeÈ,D, for a
UV dose, D, and the spectral absorption before the UV exposure, AeÈ,0:
DAl,D = Al,0 ± Al,D (1)
The mean difference of the absorbance, DA, was calculated for both,
the UVA (320±380 nm) and UVB (280±320 nm) range, called as
photoinactivation. The results are presented in Table II showing the
absorbance before UV exposure, A0, the photoinactivation for UVB and
UVA, DA, as the difference between the absorption before and after UV
exposure for following UV doses, D, of 5 SED (products A, C, E, H±
Q), 12.5 SED and 25 SED (all products), and 50 SED (products A±G),
respectively.
RESULTS
Characteristics of the investigated sunscreens Table I
shows the detailed photobiologically relevant data of the selected
suncare products. The product information printed on the packages
of the respective sunscreens promised broad-spectrum UV
protection. For all suncare products the SPF (median 20, 16±26)
was declared, whereas a quanti®cation of the protective capacity in
the UVA range was given for only two (D, N). The term
``photostability'' was mentioned in the product information of only
two sunscreens (A, L) produced by the same company. A detailed
list of active ingredients was available for all sunscreens.
Table I shows that the UV broad spectrum protective capacity
of the 16 examined sunscreens was due to a total of different ®lter
combinations. None of the examined suncare products contained
p-aminobenzoic acid (PABA) or PABA derivatives, e.g., octyl
dimethyl PABA (padimate-O), or isopropyldibenzoylmethane.
Benzophenone-3 (oxybenzone), however, was included in one
(product G) and butyl methoxydibenzoylmethane in 14 (A±F, I±Q)
of the 16 sunscreens. In all sunscreens except product C and F
organic UV ®lters were combined with one inorganic UV ®lter,
zinc oxide (ZnO) in product H or titanium dioxide (TiO2) in
suncare products A, B, D±G, and I±Q.
Wavelength-dependent change of the absorbance The
photoinactivation, DA, for all measured doses, D, are presented
for the UVA and UVB range (Table II).
Figure 1. Relative spectral erythemal effective irradiance of the
solar simulator. The cumulative erythemal effectiveness of the
simulator lies between the limits according to the COLIPA (1994)
guidelines.
Table II. Absorbancea of the suncare products (A±Q)b
before UV exposure and photoinactivationc after increasing
UV exposured
Photoinactivation, DA (%), by
biologically effective UV-exposure (SED)
Absorbance
Product A (%) 5 12.5 25 50
UVB
A 99.6 0.1 0.2 0.2 0.2
B 100.0 0.0 0.0 0.0
C 98.6 0.6 0.7 0.8 1.8
D 99.6 0.0 0.2 0.2
E 99.6 0.2 0.2 0.2 0.4
F 71.3 4.0 ±5.1 ±1.0
G 99.9 0.0 0.0 0.0
H 99.9 0.0 0.0 0.0
I 99.8 0.2 0.1 0.1
K 99.9 0.0 0.0 0.0
L 99.9 0.0 0.0 0.0
M 99.9 0.0 0.0 0.0
N 99.7 0.1 0.1 0.1
O 99.9 0.0 0.0 0.0
P 99.9 0.0 0.0 0.0
Q 99.7 0.3 0.2 0.4
UVA
A 98.5 0.3 0.6 0.3 1.6
B 99.4 15.7 28.1 29.7
C 92.6 13.0 36.3 48.4 52.0
D 99.6 0.0 0.2 0.3
E 97.7 5.3 13.8 26.5 32.7
F 57.2 11.7 12.3 27.4
G 70.9 ±1.6 ±2.0 ±3.0
H 97.2 0.0 0.0 0.2
I 98.4 7.7 13.2 24.3
K 99.9 0.1 0.0 0.0
L 99.9 0.0 0.0 0.0
M 99.9 0.0 0.1 0.5
N 99.6 0.1 0.1 0.2
O 99.9 0.0 0.1 0.6
P 96.0 17.6 23.6 22.6
Q 95.5 8.3 18.2 31.8
aData presented as mean values for the UVB (280±320 nm) and UVA (320±
380 nm) range.
bPhotounstable products are highlighted bold.
cData presented as mean values for the UVB (280±320 nm) and UVA (320±
380 nm) range. The photoinactivation is de®ned as the change of absorbance due
to UV exposure according to Eqn 1.
dUV exposure is given in standard erythema dose (SED).
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UVB In the UVB range the absorbance before UV exposure, A0,
for all products except product F showed values above 98%
(Table II). Sunscreen F had a high water content. Owing to the
rapid and signi®cant water loss during application it was dif®cult to
achieve a homogeneous layer. This seems to be the reason why the
absorbance before UV exposure, A0, for product F was only 71%.
In the UVB range, the values of the decrease of absorbance
(photoinactivation), DA, for all sunscreens and UV doses were
below 5%.
UVA In the UVA range 14 of 16 products showed an absorbance
before UV exposure, A0, of more than 90% (Table II). Only for
two products we measured an absorbance before UV exposure of
less than 90% (product F 57%, product G 71%). Contrary to the
behavior in the UVB range seven of 16 products were signi®cantly
photounstable in the UVA range, which resulted in a decrease of
the absorbance (photoinactivation), DA, between 12% (F) and 48%
(C) at 25 SED (Table II). The photoinactivation for the nine
photostable products, however, was negligible (< 1%). Figure 2
shows the spectral absorbance, AeÈ, of two selected products:
photostable sunscreen D (Fig 2a) and photounstable sunscreen C
(Fig 2b). For photostable product D there was nearly no
photoinactivation for both, the UVA and UVB range and for all
UV doses (Table II). Product C was selected by the highest values
of photoinactivation for the UVA range with increasing UV doses
(Table II). The ability of suncare product C to absorb UVB,
however, was not affected. Figure 3 shows the spectral
photoinactivation, DAl, at a UV exposure of 25 SED for all
photounstable products. With the exception of product C and F,
these products had a similar spectral behavior. As was discussed
earlier the reason for the distinct lower UVB absorbance of product
F appears to be its high water content. The decrease of the
absorbance for product C and F started at a lower wavelength
(about 320 nm) compared with all other photounstable products
(about 340 nm). All products except product F showed an
increasing photoinactivation with the wavelength. Only product
F had a maximum at 365 nm.
Dose-dependent change of the absorbance Table II shows
the dose-dependent decrease of the absorbance in the UVA range
of the seven photounstable suncare products. In order to depict the
photoinactivation as a function of wavelength and UV dose, a
contour plot was drawn for photounstable sunscreen C (Fig 4).
The lowest contour line of 5% indicates that photoinactivation
started between 320 nm and 330 nm. Above 360 nm, and for UV
doses over 20 SED the photoinactivation reached a maximum with
values above 75%. The small distances between the contour lines
(between 25% and 55% in the wavelength range between 360 nm
and 380 nm) indicates that photochemical inactivation was most
signi®cant in this area.
DISCUSSION
Sunscreens have to ful®ll a lot of quality criteria before marketing
(Shaath, 1997a). Surprisingly, a standardized assessment of photo-
stability of suncare products is not required, although it is well
known that several UV ®lter substances are inactivated by UV
radiation (Chignell et al, 1980; Gasparro, 1985; Knowland et al,
1993; Schwack and Rudolph, 1995; Allen et al, 1996; Berset et al,
1996; Schallreuter et al, 1996; Vanquerp et al, 1998; Tarras-
Wahlberg et al, 1999). This process is dose-dependent (Gasparro,
1985; Schwack and Rudolph, 1995; Allen et al, 1996; Berset et al,
1996; Tarras-Wahlberg et al, 1999) and it appears that the most
pronounced photodegradation is induced already by low UV doses
(Gasparro, 1985; Berset et al, 1996; Tarras-Wahlberg et al, 1999).
Photodecomposition of UV ®lters results in a change of absorptive
capacity (Gasparro, 1985; Berset et al, 1995; Tarras-Wahlberg et al,
1999) and the development of photoproducts (Gasparro, 1985;
Schwack and Rudolph, 1995), which might be of biologic
relevance when sunscreens are applied as thin layers on human
skin (De¯andre and Lang, 1988; Schwack and Rudolph, 1995).
The most recent data on photostability are available for oxybenzone
(benzophenone-3), which is a UVA ®lter substance frequently used
in suncare products (Schallreuter et al, 1996; Hayden et al, 1997).
Figure 2. Spectral absorbance, Al in %, of photostable product
D (a) and photounstable product C (b).
Figure 3. Spectral photoinactivation, DAl in %, of all
photounstable products (B, C, E, F, I, P, and Q) after a UV
exposure of 25 SED.
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Schallreuter et al (1996) demonstrated that oxybenzone was photo-
oxidized to its semiquinone by solar radiation in vitro and in vivo.
This reactive intermediate bound to thiolate groups in the
epidermis and inactivated the important anti-oxidant enzyme,
thioredoxin reductase. Opposite to these results (Schallreuter et al,
1996) a spectroscopic analysis of UV ®lters (Tarras-Wahlberg et al,
1999) failed to show a signi®cant photoinactivation of oxybenzone.
The reason for this disagreement may be the fact that oxybenzone
in the study by Tarras-Wahlberg et al (1999) was dissolved in a
nonpolar medium (petrolatum), whereas Schallreuter et al (1996)
used a suncare product (Soltan facial cream) where oxybenzone was
distributed in the aqueous phase. The importance of the solvent for
the behavior of a UV ®lter (Agrapidis-Paloympis et al, 1987;
Shaath, 1997b) is illustrated by a high-performance liquid
chromatography analysis by Schwack and Rudolph (1995) which
indicated that dibenzoylmethane ®lters in model solutions were
photodegraded in nonpolar solvents but were photostable in polar
solvents. Photostability tests of individual ®lters, however, do not
take into account possible interactions of ingredients of complex
®nished sunscreens (Sayre and Dowdy, 1999). Apart from the
solvent problem the photodegradation rate may be affected by
presence/absence of oxygen (Schwack and Rudolph, 1995) and
recently, Sayre and Dowdy (1999) hypothesized that photosensi-
tivity reactions induced by butyl methoxydibenzoylmethane may
be responsible for photodecomposition of certain UVB ®lters.
Another unfavorable interaction of sunscreen ingredients was
reported by Bonda and Steinberg (2000). The UV ®lter ethylhexyl
methoxycinnamate signi®cantly reduced the photostabilizing effect
of the new photostabilizer diethylhexyl naphthalate on butyl
methoxydibenzoylmethane-containing sunscreens.
The in¯uence of the solvent and possible interactions of
sunscreen ingredients were the reasons why we evaluated the
photostability of ®nished suncare products, which has been
recommended by several authors and the IARC Working Group
(Berset et al, 1996; Vanquerp et al, 1998; Sayre and Dowdy, 1999;
IARC, 2000b). In our test series seven of 16 suncare products
showed a signi®cant dose- and wavelength-dependent decrease of
the absorbance (photoinactivation) in the UVA range. The
decrease of absorbance in the UVA range started between
320 nm and 335 nm with a maximum above 350 nm. Neither
complex combinations of different organic ®lters nor the addition
of inorganic ®lters could absolutely prevent photoinactivation. All
photounstable products contained three or ®ve organic ®lters and
all but products C and F contained an inorganic ®lter. Our data
clearly show that the behavior of a complete product when exposed
to UV radiation could not be predicted from the behavior of the
individual ®lter substances it was composed of. In contrast to the
photounstable sunscreens B, I, and Q, suncare product M was not
photoinactivated, although all of them had identical ®lters. The
same was true for photounstable product E that contained the same
®lter combination as the photostable sunscreens K and O.
Furthermore, the presence of a photounstable UV ®lter among
the list of ingredients of a certain sunscreen did not necessarily result
in photoinstability of the complete suncare product. This could be
shown for products that contained butyl methoxydibenzoyl-
methane or oxybenzone. In our test series only photostable
sunscreen G contained oxybenzone and butyl methoxydibenzoyl-
methane was found in both, photostable (A, D, K±O) and
photounstable sunscreens (B, C, E, F, I, P, Q). Two recent studies
(Diffey et al, 1997; Sayre and Dowdy, 1999) reported comparable
results. Diffey et al (1997) showed that in a series of nine products
only four sunscreens were photostable. Sayre and Dowdy (1999)
presented data on dose-dependent photodegradation of six butyl
methoxydibenzoylmethane-containing sunscreens. Both studies
(Diffey et al, 1997; Sayre and Dowdy, 1999) are in agreement
with our observation that photoinactivation was most pronounced
in the wavelength range above 350 nm and after the ®rst fraction of
UV exposure (Table II).
Photounstable UV ®lters may damage human skin by two
mechanisms which, at the end, are closely related and most likely
boost each other. First, UV ®lters may behave as exogenous UVA
sensitizers. During photolysis of photounstable UV ®lters reactive
intermediates are produced (Chignell et al, 1980; Gasparro, 1985;
Dalle Carbonare and Pathak, 1992; Schwack and Rudolph, 1995;
Allen et al, 1996; Schallreuter et al, 1996; Tarras-Wahlberg et al,
1999). Free radicals may induce formation of reactive oxygen
species (ROS) (Dalle Carbonare and Pathak, 1992; Allen et al,
1996) which have toxic effects (Dalle Carbonare and Pathak, 1992;
Shindo et al, 1994; Schallreuter et al, 1996; McHugh and
Knowland, 1997) or may bind to proteins or DNA (Dalle
Carbonare and Pathak, 1992). Second, a dose-dependent decrease
of the UVA absorptive capacity results in an increase of the direct
UVA-induced skin damage.
According to the free radical theory of photoaging of human skin
generation of ROS results in the formation of protein cross-links in
collagen and certain enzymes such as catalase and superoxide
dismutase (Dalle Carbonare and Pathak, 1992). These authors
showed that protein inactivation was more signi®cant by UVA
irradiation in the presence of sensitizers than by UVA without
sensitizers. There is increasing evidence that oxidative stress is
involved in skin carcinogenesis. ROS seem to be responsible for
the induction of 8-hydroxy-2¢-deguanosin in arsenic-related
nonmelanoma skin cancer (Matsui et al, 1999). The presence of
8-hydroxy-2¢-deguanosin-mediated DNA defects in UV-induced
skin cancers in mice (Nishigori et al, 1994) indicated ROS as
cofactors of photocarcinogenesis. This seems to be the mechanism
for the signi®cantly higher number of strandbreaks of single-
stranded DNA by UV irradiation in the presence of octyl dimethyl
PABA (padimate-O) when compared with UV irradiation alone
(McHugh and Knowland, 1997). In basal keratinocytes padimate-
O signi®cantly increased indirect DNA damage (strand breaks)
when exposed to UV radiation even though the sunscreen ®lm
reduced direct UV damage (Gulston and Knowland, 1999). This
indirect (ROS-mediated) DNA damage could be suppressed
completely by oxygen quenchers. The study by Gulston and
Knowland (1999), therefore, strongly supports the model of a dual
mechanism of UVA-induced skin damage. Surprisingly, padimate-
O, which penetrates the skin (Kenney et al, 1995), is still advertised
as a chemically inert, safe, and photostable UVB ®lter (Klein,
1997). Photoinstability of UV ®lters may be responsible for the
high frequency of photosensitive reactions induced by sunscreens.
The hypothesis that reactive photolysis products may behave as
haptens or induce toxic cell damage (Chignell et al, 1980) is
supported by the results of three recent studies presenting the patch
and photopatch test results in persons with suspected photosensi-
tivity to sunscreen ingredients (Szcurko et al, 1994; Schauder and
Figure 4. Contour plot of the photoinactivation, DAl,D, as a
function of the UV dose, D, and the wavelength, l, for
photounstable product C showing a distinct photoinstability.
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Ippen, 1997; Journe et al, 1999). In their review of 402 patients
Schauder and Ippen (1997) found that UVA ®lters were responsible
for the majority of positive photopatch test results (54 reactions)
when compared with UVB ®lters (30 reactions). The photo-
unstable absorbers isopropyldibenzoylmethane and butyl methox-
ydibenzoylmethane gave 32 and 13 positive reactions, respectively.
Photostable terephthalylidene dicamphor sulfonic acid, however,
showed no positive reactions in this follow-up. The most important
photosensitizers in the survey by Szczurko et al (1994) were
oxybenzone, octyl dimethyl PABA and isopropyldibenzoyl-
methane and in the follow-up by Journe et al (1999) oxybenzone
and isopropyl dibenzoylmethane.
Until recently, micro®ne inorganic ®lters seemed to be ideal
ingredients to provide broad-spectrum UV protection and to
maintain photostability of sunscreens (Anderson et al, 1997;
Mitchnick et al, 1999). Dunford et al (1997), however, showed
that micro®ne ZnO and TiO2 not only scattered and re¯ected but
effectively absorbed UV radiation thus initiating ROS formation
and catalyzing DNA damage. For uncoated ZnO and for both, the
coated and uncoated TiO2 Mitchnick et al (1999) measured a
signi®cant photocatalytic potential (ZnO < < TiO2), whereas the
photoreactivity of coated micro®ne ZnO appeared to be negligible.
As long as relevant transepidermal penetration of microparticles
cannot be excluded de®nitely (Lademann et al, 1999) the
photocatalytic potential of inorganic sunscreen ingredients is of
importance and should be further investigated (IARC, 2000b).
It is well known that suberythemogenic UVA doses do cause
various biologic effects (Tyrrell, 1995). UVA induced nonmela-
noma skin cancer in SKH1 hairless albino mice (de Gruijl et al,
1993), although it was far less effective than UVB. The p53
expression induced by UVA was only half of that induced by
biologically equivalent doses of solar-simulated radiation, pyrimi-
dine dimer formation, however, was the same (Burren et al, 1998).
Setlow et al (1993) de®ned an action spectrum for ®sh melanoma
with a carcinogenic peak at 365 nm wavelength in the UVA range.
The importance of UVA radiation for the development of
melanoma in humans, however, is not clear as yet. Several studies
agree that UVA appears to participate in the photoaging process
more effectively than originally suspected (Menter et al, 1996;
Berneburg et al, 1999). The effect of UVA on the immune system,
however, is still a matter for debate. Cowell et al2 showed that solar
radiation or solar-simulated radiation had a higher immunosup-
pressive potential than UVB radiation. This is the reason why Serre
et al (1997) proposed that only sunscreens with medium SPF and
high UVA protection adequately protect from photoimmunosup-
pression. Recent studies questioned the hypothesis of an im-
munosuppressive action of UVA (Halliday et al, 1998; Iwai et al,
1999) and indicated that UVA may provide some protection against
UVB-induced immunosuppression (Reeve et al, 1998, 1999;
Reeve and Tyrrell, 1999). Direct UV damage of nonenzymatic
and enzymatic anti-oxidants (Dalle Carbonare and Pathak, 1992;
Shindo et al, 1994; Schallreuter et al, 1996; Poswig et al, 1999)
should not be underestimated as a causative factor for skin damage
but in the case of superoxide dismutase appears to be dependent on
the irradiation mode (Shindo et al, 1994; Poswig et al, 1999).
As was shown, the behavior of a sunscreen could not be
predicted from the behavior of its individual ingredients. Neither
the combination of various organic ®lters nor the addition of
inorganic ®lters were able to guarantee photostability. What is most
striking is that photoinactivation was not a phenomenon of high
UV doses but appears to take place at doses that can easily be
acquired by sunbathers. We therefore conclude that only photo-
stable organic ®lters should be used and that the safety of inorganic
UV ®lter substances must be re-evaluated. A standardized assess-
ment of the photostability of suncare products should be a general
requirement before marketing.
We gratefully acknowledge Professor Schauder, Professor Schallreuter, and Professor
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